Cargando…

High prevalence of HER-2/neu overexpression in female breast cancer among an Iraqi population exposed to depleted uranium

BACKGROUND: This study aimed to estimate the rate of HER-2/neu (c-erbB2) immunohistochemical overexpression in different histological types of breast cancer found in the middle Euphrates region of Iraq, a region that was exposed to high levels of depleted uranium. HER-2/neu (c-erbB2) overexpression...

Descripción completa

Detalles Bibliográficos
Autores principales:	AL-Dujaily, Esraa A., Al-Janabi, Asad A., Pierscionek, Tomasz, Yasseen, Akeel A.
Formato:	Texto
Lenguaje:	English
Publicado:	Medknow Publications 2008
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2669727/ https://www.ncbi.nlm.nih.gov/pubmed/19008567 http://dx.doi.org/10.4103/1477-3163.44026

Ejemplares similares

Exposure to depleted uranium does not alter the co-expression of HER-2/neu and p53 in breast cancer patients
por: Al-Mumen, Mais M, et al.
Publicado: (2011)

Increased PTEN gene expression in patients with endometrial carcinoma from areas of high risk depleted uranium exposure
por: Jumaah, Alaa Salah, et al.
Publicado: (2019)

Specific-mutational patterns of p53 gene in bladder transitional cell carcinoma among a group of Iraqi patients exposed to war environmental hazards
por: Al-Kashwan, Thekra A, et al.
Publicado: (2012)

Vascular endothelial growth factor (VEGF) receptor expression correlates with histologic grade and stage of colorectal cancer
por: Hashim, Ali F., et al.
Publicado: (2010)

SNP-PCR genotyping links alterations in the GABAA receptor (GABRG3: rs208129) and RELN (rs73670) genes to autism spectrum disorder among peadiatric Iraqi Arabs
por: Ali, Zainab A., et al.
Publicado: (2022)

Anti-Her-2/neu antibody induces apoptosis in Her-2/neu overexpressing breast cancer cells independently from p53 status
por: Brodowicz, T, et al.
Publicado: (2001)

Whole transcriptome data of zebrafish exposed to chronic dose of depleted uranium
por: Armant, Olivier, et al.
Publicado: (2017)

Uranium concentration in blood samples of Southern Iraqi leukemia patients using CR-39 track detector
por: Al-Hamzawi, Anees A., et al.
Publicado: (2013)

Functional assay for HER-2/neu demonstrates active signalling in a minority of HER-2/neu-overexpressing invasive human breast tumours.
por: DiGiovanna, M. P., et al.
Publicado: (1996)

Trafficking of High Avidity HER-2/neu-Specific T Cells into HER-2/neu-Expressing Tumors after Depletion of Effector/Memory-Like Regulatory T Cells
por: Weiss, Vivian L., et al.
Publicado: (2012)

ACOL depleted uranium
Publicado: (1987)

The Toxicity of Depleted Uranium
por: Briner, Wayne
Publicado: (2010)

Inhibition of Cell Growth and Induction of Apoptosis by Antrodia camphorata in HER-2/neu-Overexpressing Breast Cancer Cells through the Induction of ROS, Depletion of HER-2/neu, and Disruption of the PI3K/Akt Signaling Pathway
por: Lee, Chuan-Chen, et al.
Publicado: (2012)

HER2/neu overexpression in the development of muscle-invasive transitional cell carcinoma of the bladder
por: Latif, Z, et al.
Publicado: (2003)

Chromogenic in Situ Hybridization Technique versus Immunohistochemistry in Assessment of HER2/neu Status in 448 Iraqi Patients with Invasive Breast Carcinoma
por: Ali, Ali Hussein Mohammed, et al.
Publicado: (2019)

Management of depleted uranium : a joint report /
Publicado: (2001)

TOPOIIα and HER-2/neu overexpression/amplification in Barrett’s oesophagus, dysplasia and adenocarcinoma
por: Rossi, Elisa, et al.
Publicado: (2010)

cERBB-2/Her-2 Neu Overexpression and Prognostic Significance in Uterine Carcinosarcoma
por: Semiz, Huseyin Salih, et al.
Publicado: (2023)

Expression of HER-2/neu in Oral Squamous Cell Carcinoma
por: Mirza, Sana, et al.
Publicado: (2020)

Breast Cancer and Her-2/Neu
por: Sherwood, Roy
Publicado: (2005)

A Review on Toxicodynamics of Depleted Uranium
por: Shaki, Fatemeh, et al.
Publicado: (2019)

Current Impact and Long-Term Influence of the COVID-19 Pandemic on Iraqi Healthcare Systems: A Case Study
por: Al Janabi, Taysir, et al.
Publicado: (2022)

Uranium XAFS analysis of kidney from rats exposed to uranium
por: Kitahara, Keisuke, et al.
Publicado: (2017)

HER-2/neu Testing and Therapy in Gastroesophageal Adenocarcinoma
por: Moelans, Cathy B., et al.
Publicado: (2010)

Overexpression of miR-489 derails mammary hierarchy structure and inhibits HER2/neu-induced tumorigenesis
por: Patel, Y, et al.
Publicado: (2018)

Effects of HSP90 inhibitor 17-allylamino-17-demethoxygeldanamycin (17-AAG) on NEU/HER2 overexpressing mammary tumours in MMTV-NEU-NT mice monitored by Magnetic Resonance Spectroscopy
por: Rodrigues, Loreta M, et al.
Publicado: (2012)

Clinical significance of Akt and HER2/neu overexpression in African-American and Latina women with breast cancer
por: Wu, Yanyuan, et al.
Publicado: (2008)

Prognostic Value of KIF2A and HER2-Neu Overexpression in Patients With Epithelial Ovarian Cancer
por: Wang, Di, et al.
Publicado: (2016)

Biological Monitoring for Depleted Uranium Exposure in U.S. Veterans
por: Dorsey, Carrie D., et al.
Publicado: (2009)

HER-2/neu diagnostics in breast cancer
por: Carney, Walter P, et al.
Publicado: (2007)

The Clinical Importance of the Heterogeneity of HER2 neu
por: Davila, Enrique, et al.
Publicado: (2010)

The toxicological mechanisms and detoxification of depleted uranium exposure
por: Yue, Yong-Chao, et al.
Publicado: (2018)

Exploring the Toxicology of Depleted Uranium with Caenorhabditis elegans
por: Lu, Meiling, et al.
Publicado: (2020)

Dose escalation and pharmacokinetic study of a humanized anti-HER2 monoclonal antibody in patients with HER2/neu-overexpressing metastatic breast cancer
por: Tokuda, Y, et al.
Publicado: (1999)

Adjuvant effect of HER-2/neu-specific adenoviral vector stimulating CD8(+) T and natural killer cell responses on anti-HER-2/neu antibody therapy for well-established breast tumors in HER-2/neu transgenic mice
por: Chen, Y, et al.
Publicado: (2011)

Societal Costs and Benefits of Treatment with Trastuzumab in Patients with Early HER2neu-Overexpressing Breast Cancer in Singapore
por: de Lima Lopes, Gilberto
Publicado: (2011)

Expression of Septin 2 and Her2/neu in Colorectal Cancer
por: Hanbuli, Hala M. El, et al.
Publicado: (2021)

Serological Her2/neu-determination in patients receiving Herceptin(®)
por: Thomas, A, et al.
Publicado: (2001)

HER 2/neu protein expression in colorectal cancer
por: Schuell, B, et al.
Publicado: (2006)

Anti-HER2/Neu passive-aggressive immunotherapy
por: Mortenson, Eric D, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_6ncind7mgui2tkps7t5gdum7ht